Physician profile
Felix Chen
NPI 1861059875
$1,935.23
in general payments reported to CMS, 2019-2025
16 companies · $832 in 2025
The $832 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.65 · 2022: $241 · 2023: $245 · 2024: $596 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,673.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $425.00 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $295.71 | 2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $230.05 | 2023-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $144.72 | 2022-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Alexion Pharmaceuticals, INC. | $135.46 | 2024 | Strensiq |
| Gilead Sciences, INC. | $135.00 | 2024 | Vemlidy |
| Exact Sciences Corporation | $131.63 | 2023 | Cologuard Collection Kit |
| Madrigal Pharmaceuticals | $128.88 | 2025 | Rezdiffra |
| Astrazeneca Pharmaceuticals Lp | $118.04 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.00 | 2025 | |
| Fidia Pharma USA INC. | $26.00 | 2023 | Triluron, Hymovis |
| Sanofi-Aventis U.S. LLC | $21.83 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.65 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.63 | 2022 | |
| Pfizer INC. | $16.39 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.24 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felix Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.